# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-007375
Filing Date
2022-05-04
Accepted
2022-05-04 16:05:25
Documents
77
Period of Report
2022-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | srpt-20220331.htm iXBRL | 10-Q | 3370139
2 | EX-10.1 | srpt-ex10_1.htm | EX-10.1 | 98613
3 | EX-31.1 | srpt-ex31_1.htm | EX-31.1 | 14901
4 | EX-31.2 | srpt-ex31_2.htm | EX-31.2 | 15014
5 | EX-32.1 | srpt-ex32_1.htm | EX-32.1 | 10596
6 | EX-32.2 | srpt-ex32_2.htm | EX-32.2 | 10424
| Complete submission text file | 0000950170-22-007375.txt |  | 10472180

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | srpt-20220331_pre.xml | EX-101.PRE | 331650
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | srpt-20220331_cal.xml | EX-101.CAL | 71323
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | srpt-20220331_lab.xml | EX-101.LAB | 443086
10 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | srpt-20220331.xsd | EX-101.SCH | 61240
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | srpt-20220331_def.xml | EX-101.DEF | 183068
71 | EXTRACTED XBRL INSTANCE DOCUMENT | srpt-20220331_htm.xml | XML | 1988510

Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

EIN.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 22891474
SIC: 2834 Pharmaceutical Preparations